Top Scoops

Book Reviews | Gordon Campbell | Scoop News | Wellington Scoop | Community Scoop | Search

 

Government may provide indemnity to NZ supplier of Covid-19 vaccine

The Ministry of Health is planning to fast-track the approval process for a Covid-19 vaccine, and won't rule out offering a supplier indemnity from any potential claims resulting from its use.

Research is under way worldwide to find a safe vaccine for Covid-19. Photo: AFP

It said Medsafe will ensure a vaccine is safe for use, and it will not be used on people unless clinical data suggests it is safe and effective.

A vaccine is the golden ticket back to normality, and is eagerly sought by people throughout the world.

This week, pharmaceutical companies Moderna and Pfizer announced they were launching trials of a Covid-19 vaccine which they say, if successful, could lead to approval and widespread use by the end of the year.

More than 150 coronavirus vaccine candidates are in various stages of development, with some two dozen prospects already conducting human testing.

Politicians are wanting to rush them into use when they are ready to go.

New Zealand is no different, and a Ministry of Health spokesperson said in a statement that it is looking at how it approves vaccines.

"As part of the Covid-19 vaccine strategy, the Ministry is working to develop an expedited regulatory approval process that will still maintain standards," the statement read.

"Medsafe will ensure that any vaccine for Covid -19 will be of acceptable efficacy, quality and safety before it is used in New Zealand.

"Clinical data will be required to ensure any vaccine is safe and effective before it is used on people. The process will be run by Medsafe."

The Ministry did not rule out offering indemnity to a vaccine supplier, as has happened previously.

Documents obtained under the Official Information Act show the previous Labour government accepted liability when it sourced a bird flu vaccine.

In May 2007, the Ministry of Health obtained 100,000 vaccines from Baxter Healthcare, at a cost of up to $3.4 million.

But as part of the purchase, the government had to provide indemnity to Baxter.

"It is not practical to conduct a normal trials process with this vaccine, so Baxter cannot license the vaccine in the normal way," the report, sent to then-Finance Minister Michael Cullen, and then-Health Minister Pete Hodgson, said.

"It is also not possible to know ahead of time how effective the vaccine will be against any H5 pandemic virus that may develop within the shelf life of the vaccine."

The Ministry said every potential supplier of the vaccine had the same conditions - indemnity "from any claims arising from the use of the vaccine".

While it was deemed a financial risk, it was determined to be worth it for the potential benefits if the bird flu pandemic worsened.

RNZ has put questions to Megan Woods, the Minister of Research, Science and Innovation who is leading the vaccine strategy work, about whether the government would consider taking liability for a Covid-19 vaccine. But she said it is not for her to say how the government would respond.

See all RNZ coverage of Covid-19

Meanwhile, as part of that strategy, Pharmac said it is seeking information "regarding Covid-19 vaccine research, manufacture and supply, including supplier willingness to consider a range of different commercial scenarios for supply to New Zealand".

It said it has not sought commercial proposals for the supply of a vaccine.

Pharmac listed eight technology platforms it is considering for a vaccine, but said it is open to other technology also.

The vaccine types were: Inactivated virus; live attenuated virus; DNA-based vaccine; RNA-based vaccine; non-replicating viral vector; replicating viral vector; protein subunit; and virus-like particle.

The government has dedicated $37m to the Covid-19 vaccine strategy, which includes support for local research and manufacturing, and support for international research.

© Scoop Media

 
 
 
Top Scoops Headlines

 

The Conversation: Rogue Poll Or Not, All The Signs Point To A Tectonic Shift In New Zealand Politics

Richard Shaw AAP(various)/NZ Greens (CC-BY-SA)/The Conversation Strong team. More jobs. Better economy. So say the National Party’s campaign hoardings. Only thing is, last Sunday’s Newshub-Reid Research poll – which had support for the Labour ... More>>

Dunne Speaks: It's Time For Matariki Day

The period of Matariki, the celebration of the Māori New Year, which began earlier this week, is being celebrated increasingly as an important national event. While many other countries have their own form of New Year celebrations, Matariki is uniquely ... More>>

Gordon Campbell: On Why We Shouldn’t Be Pushed Into Re-Opening Our Borders

I believe in yesterday as much as Paul McCartney, but it was bemusing to see the amount of media attention lavished last week on the pandemic-related musings by former government science adviser Sir Peter Gluckman, former Prime Minister Helen Clark ... More>>

Gordon Campbell: On The Media Collusion With National’s Attack Lines

For most of the past week, any consumer of this country’s management of Covid-19 would think New Zealand was actually Brazil, or Texas. The media language has been full of claims of “botches” at the border, and laxness and inexcusable errors ... More>>

The Coronavirus Republic: Three Million Infections And Rising

The United States is famed for doing things, not to scale, but off it. Size is the be-all and end-all, and the coronavirus is now doing its bit to assure that the country remains unrivalled in the charts of infection . In time, other unfortunates may well ... More>>

Binoy Kampmark: Altars Of Hypocrisy: George Floyd, Protest And Black Face

Be wary what you protest about. The modern moral constabulary are out, and they are assisted by their Silicon Valley friends in the Social Media club. Should you dare take a stand on anything, especially in a dramatic way, you will be found out ... More>>

Binoy Kampmark: Welcome Deaths: Coronavirus And The Open Plan Office

For anybody familiar with that gruesome manifestation of the modern work place, namely the open plan office, the advent of coronavirus might be something of a relief. The prospects for infection in such spaces is simply too great. You are at risk from ... More>>


Binoy Kampmark: Why Thinking Makes It So: Donald Trump’s Obamagate Fixation

The “gate” suffix has been wearing thin since the break-in scandal that gave it its birth. Since Watergate, virtually anything dubious and suggestive, and much more besides, is suffixed. Which brings us to the issue of President Donald Trump’s ... More>>